This week is World Antimicrobial Awareness Week, marking the fight against the silent and rising global threat of antimicrobial-resistant superbugs. Can patients be part of the solution? This week is the World Antimicrobial Awareness Week (WAAW) when we turn the world’s attention to the growing problem of drug resistant diseases – caused by bacteria, viruses […] Continue reading ->
Second in a series – On Wednesday, 18 November, at 2pm CET, leading experts at the Geneva Health Forum (GHF) 2020 will provide their take on how to move forward on the recently approved WHO global strategy to accelerate the elimination of cervical cancer, which kills 300,000 women every year, mostly in low-resource settings like […] Continue reading ->
A series of new COVID-19 drug and vaccine funding commitments worth just over US$300 million were announced on Thursday by the Gates Foundation, France and the European Commission – amidst a quickening pace of anticipation that at least one, if not two, COVID-19 vaccines may soon become available. Appearing at the Paris Peace Forum, Melinda […] Continue reading ->
First in a Series: While COVID continues to cast a long shadow over our everyday lives, from Baku, Azerbaijan to Bogota, Columbia, there are also countless examples of how cities and communities have mobilized to respond to the social and economic fallout from the pandemic – building new forms of cooperation that also promote a […] Continue reading ->
The COVID-19 pandemic will end at some point. But TB, tobacco use, air pollution and other lung diseases will continue to “steal the breath and life of millions of people every year”, unless we reimagine the future, said WHO’s director-general Dr Tedros Adhanon Ghebreyesus, appearing at the opening of the 51st Union World Conference On […] Continue reading ->
The world must take urgent action to end the global tuberculosis epidemic by 2030, especially as the pandemic threatens to unwind hard-won progress made in past decades, concluded the WHO’s 2020 Global Tuberculosis Report on Wednesday. While the WHO European region is on track to achieve key 2020 targets, the rest of the world has […] Continue reading ->
As global stocks of remdesivir, one of the few promising therapeutics for COVID-19, run low, the drug’s maker Gilead Sciences says that voluntary licensing to enable more manufacturers to produce the drug will not help expand access, countering advocates’ calls. Rather, the lack of a “coordinated global supply chain” is to blame for worldwide shortages […] Continue reading ->
European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading ->
The United Nations Interagency Coordination Group (IACG) is seeking candidates for a “One Health Global Leaders Group” that will be established to fight the growing threat of antimicrobial resistance (AMR). Individuals from civil society and the private sector are invited to submit an application to serve in the Global Leaders Group by 31 August 2020. […] Continue reading ->
About 1.7 billion people, or 22% of the world’s population, has at least one underlying health condition that puts them at increased risk of becoming seriously ill with COVID-19, according to a new modelling study published in Lancet Global Health. Based on the new assessment, about 4% of the world’s population, in total, is at […] Continue reading ->
You must be logged in to post a comment.